PDB Short entry for 2G5O HEADER HORMONE/GROWTH FACTOR RECEPTOR 23-FEB-06 2G5O TITLE HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 2- TITLE 2 (BUT-1-ENYL)-17BETA-ESTRADIOL AND A GLUCOCORTICOID RECEPTOR TITLE 3 INTERACTING PROTEIN 1 NR BOX II PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: ER, ESTRADIOL RECEPTOR, ER-ALPHA; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 2; COMPND 10 CHAIN: C, D; COMPND 11 FRAGMENT: GRIP PEPTIDE; COMPND 12 SYNONYM: NCOA-2, TRANSCRIPTIONAL INTERMEDIARY FACTOR 2; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: MCSG7 (PET12-DERIVATIVE); SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN HOMO SAPIENS SOURCE 14 (HUMANS). KEYWDS ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, HORMONE-GROWTH FACTOR RECEPTOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.S.RAJAN,R.W.HSIEH,S.K.SHARMA,G.L.GREENE REVDAT 5 30-AUG-23 2G5O 1 REMARK REVDAT 4 20-OCT-21 2G5O 1 REMARK SEQADV LINK REVDAT 3 13-JUL-11 2G5O 1 VERSN REVDAT 2 24-FEB-09 2G5O 1 VERSN REVDAT 1 06-MAR-07 2G5O 0 JRNL AUTH R.W.HSIEH,G.L.GREENE JRNL TITL HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN JRNL TITL 2 COMPLEX WITH 2-(BUT-1-ENYL)-17BETA-ESTRADIOL AND A JRNL TITL 3 GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II JRNL TITL 4 PEPTIDE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.65 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 21070 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1134 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1556 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.37 REMARK 3 BIN R VALUE (WORKING SET) : 0.2510 REMARK 3 BIN FREE R VALUE SET COUNT : 73 REMARK 3 BIN FREE R VALUE : 0.2600 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4001 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 32 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.03000 REMARK 3 B22 (A**2) : 0.05000 REMARK 3 B33 (A**2) : -0.07000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.08000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.463 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.275 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.204 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 17.614 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4147 ; 0.008 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5598 ; 1.130 ; 1.999 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 490 ; 4.951 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 177 ;37.688 ;24.011 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 774 ;20.511 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 24 ;22.122 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 656 ; 0.080 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2954 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2034 ; 0.233 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2823 ; 0.321 ; 0.500 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 226 ; 0.156 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 40 ; 0.218 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 5 ; 0.452 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2550 ; 0.851 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3989 ; 1.425 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1778 ; 0.823 ; 2.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1609 ; 1.245 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 3 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 304 A 548 4 REMARK 3 1 B 304 B 548 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 1877 ; 0.61 ; 0.50 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1877 ; 0.62 ; 2.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : C D REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 C 687 C 696 4 REMARK 3 1 D 688 D 696 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 2 C (A): 79 ; 0.65 ; 0.50 REMARK 3 MEDIUM THERMAL 2 C (A**2): 79 ; 0.51 ; 2.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 3 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 201 A 201 4 REMARK 3 1 B 555 B 555 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 3 A (A): 24 ; 0.11 ; 0.50 REMARK 3 MEDIUM THERMAL 3 A (A**2): 24 ; 0.28 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 304 A 548 REMARK 3 ORIGIN FOR THE GROUP (A): -15.4186 0.1577 -1.7680 REMARK 3 T TENSOR REMARK 3 T11: -0.1040 T22: -0.1584 REMARK 3 T33: -0.1471 T12: -0.0130 REMARK 3 T13: 0.0424 T23: 0.0008 REMARK 3 L TENSOR REMARK 3 L11: 2.9335 L22: 2.0200 REMARK 3 L33: 2.7960 L12: 0.3245 REMARK 3 L13: 0.8290 L23: 0.3532 REMARK 3 S TENSOR REMARK 3 S11: -0.0560 S12: 0.0469 S13: -0.1056 REMARK 3 S21: -0.2499 S22: 0.0207 S23: 0.0666 REMARK 3 S31: 0.0055 S32: -0.0063 S33: 0.0353 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 304 B 550 REMARK 3 ORIGIN FOR THE GROUP (A): -23.8992 -0.5220 22.2724 REMARK 3 T TENSOR REMARK 3 T11: -0.1046 T22: -0.1395 REMARK 3 T33: -0.1788 T12: -0.0137 REMARK 3 T13: -0.0086 T23: -0.0160 REMARK 3 L TENSOR REMARK 3 L11: 4.3365 L22: 1.6755 REMARK 3 L33: 1.1483 L12: 0.8626 REMARK 3 L13: -1.0583 L23: 0.1288 REMARK 3 S TENSOR REMARK 3 S11: 0.1488 S12: -0.0372 S13: 0.0300 REMARK 3 S21: 0.0200 S22: -0.0632 S23: 0.1029 REMARK 3 S31: 0.0315 S32: 0.2227 S33: -0.0855 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 687 C 696 REMARK 3 ORIGIN FOR THE GROUP (A): -20.1825 -17.6266 -10.8931 REMARK 3 T TENSOR REMARK 3 T11: 0.3392 T22: -0.2057 REMARK 3 T33: -0.0668 T12: -0.0563 REMARK 3 T13: 0.0090 T23: -0.1179 REMARK 3 L TENSOR REMARK 3 L11: 63.7276 L22: 15.2370 REMARK 3 L33: 29.2735 L12: -2.7197 REMARK 3 L13: 23.8796 L23: 4.4059 REMARK 3 S TENSOR REMARK 3 S11: -0.0968 S12: 0.3585 S13: -3.2545 REMARK 3 S21: -0.2733 S22: -0.3700 S23: 1.0648 REMARK 3 S31: 2.1632 S32: -2.1044 S33: 0.4668 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 688 D 696 REMARK 3 ORIGIN FOR THE GROUP (A): -33.9057 16.2555 27.1543 REMARK 3 T TENSOR REMARK 3 T11: -0.1600 T22: -0.3171 REMARK 3 T33: 0.0389 T12: -0.0086 REMARK 3 T13: 0.1211 T23: -0.1390 REMARK 3 L TENSOR REMARK 3 L11: 21.7246 L22: 22.3620 REMARK 3 L33: 5.2238 L12: -10.7885 REMARK 3 L13: -6.4901 L23: -4.2508 REMARK 3 S TENSOR REMARK 3 S11: -0.2640 S12: -0.1481 S13: 1.2468 REMARK 3 S21: 0.4235 S22: -0.0010 S23: 0.3712 REMARK 3 S31: -0.5298 S32: -0.8154 S33: 0.2650 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2G5O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-MAR-06. REMARK 100 THE DEPOSITION ID IS D_1000036719. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-OCT-05 REMARK 200 TEMPERATURE (KELVIN) : 77.0 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 14-BM-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : BENT GE(111) MONOCHROMATOR REMARK 200 OPTICS : BENT CONICAL SI-MIRROR (RH REMARK 200 COATED) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22324 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.08400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.9540 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.2 REMARK 200 DATA REDUNDANCY IN SHELL : 5.20 REMARK 200 R MERGE FOR SHELL (I) : 0.38500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.560 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1ZKY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M MAGENESIUM CHLORIDE 0.1M TRIS P REMARK 280 8.0 25% PEG 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 289K, PH 8.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.67350 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6880 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20500 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -49.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 298 REMARK 465 LYS A 299 REMARK 465 ARG A 300 REMARK 465 SER A 301 REMARK 465 LYS A 302 REMARK 465 LYS A 303 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 LYS A 467 REMARK 465 SER A 468 REMARK 465 LEU A 549 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 THR A 553 REMARK 465 SER A 554 REMARK 465 ILE B 298 REMARK 465 LYS B 299 REMARK 465 ARG B 300 REMARK 465 SER B 301 REMARK 465 LYS B 302 REMARK 465 LYS B 303 REMARK 465 SER B 463 REMARK 465 SER B 464 REMARK 465 THR B 465 REMARK 465 LEU B 466 REMARK 465 LYS B 467 REMARK 465 SER B 468 REMARK 465 LEU B 469 REMARK 465 GLU B 470 REMARK 465 ALA B 551 REMARK 465 PRO B 552 REMARK 465 THR B 553 REMARK 465 SER B 554 REMARK 465 LYS C 686 REMARK 465 SER C 697 REMARK 465 SER C 698 REMARK 465 LYS D 686 REMARK 465 HIS D 687 REMARK 465 SER D 697 REMARK 465 SER D 698 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 330 30.26 -94.53 REMARK 500 PRO A 333 8.82 -64.06 REMARK 500 THR A 371 151.54 -49.20 REMARK 500 LEU B 306 1.20 -64.01 REMARK 500 GLU B 330 47.28 -90.37 REMARK 500 PRO B 333 29.33 -77.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DRQ A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DRQ B 555 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2G44 RELATED DB: PDB DBREF 2G5O A 298 554 UNP P03372 ESR1_HUMAN 298 554 DBREF 2G5O B 298 554 UNP P03372 ESR1_HUMAN 298 554 DBREF 2G5O C 686 698 UNP Q15596 NCOA2_HUMAN 686 698 DBREF 2G5O D 686 698 UNP Q15596 NCOA2_HUMAN 686 698 SEQADV 2G5O CME A 381 UNP P03372 CYS 381 MODIFIED RESIDUE SEQADV 2G5O CME A 417 UNP P03372 CYS 417 MODIFIED RESIDUE SEQADV 2G5O CME A 530 UNP P03372 CYS 530 MODIFIED RESIDUE SEQADV 2G5O SER A 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQADV 2G5O CME B 381 UNP P03372 CYS 381 MODIFIED RESIDUE SEQADV 2G5O CME B 417 UNP P03372 CYS 417 MODIFIED RESIDUE SEQADV 2G5O CME B 530 UNP P03372 CYS 530 MODIFIED RESIDUE SEQADV 2G5O SER B 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQRES 1 A 257 ILE LYS ARG SER LYS LYS ASN SER LEU ALA LEU SER LEU SEQRES 2 A 257 THR ALA ASP GLN MET VAL SER ALA LEU LEU ASP ALA GLU SEQRES 3 A 257 PRO PRO ILE LEU TYR SER GLU TYR ASP PRO THR ARG PRO SEQRES 4 A 257 PHE SER GLU ALA SER MET MET GLY LEU LEU THR ASN LEU SEQRES 5 A 257 ALA ASP ARG GLU LEU VAL HIS MET ILE ASN TRP ALA LYS SEQRES 6 A 257 ARG VAL PRO GLY PHE VAL ASP LEU THR LEU HIS ASP GLN SEQRES 7 A 257 VAL HIS LEU LEU GLU CME ALA TRP LEU GLU ILE LEU MET SEQRES 8 A 257 ILE GLY LEU VAL TRP ARG SER MET GLU HIS PRO GLY LYS SEQRES 9 A 257 LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN SEQRES 10 A 257 GLY LYS CME VAL GLU GLY MET VAL GLU ILE PHE ASP MET SEQRES 11 A 257 LEU LEU ALA THR SER SER ARG PHE ARG MET MET ASN LEU SEQRES 12 A 257 GLN GLY GLU GLU PHE VAL CYS LEU LYS SER ILE ILE LEU SEQRES 13 A 257 LEU ASN SER GLY VAL TYR THR PHE LEU SER SER THR LEU SEQRES 14 A 257 LYS SER LEU GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU SEQRES 15 A 257 ASP LYS ILE THR ASP THR LEU ILE HIS LEU MET ALA LYS SEQRES 16 A 257 ALA GLY LEU THR LEU GLN GLN GLN HIS GLN ARG LEU ALA SEQRES 17 A 257 GLN LEU LEU LEU ILE LEU SER HIS ILE ARG HIS MET SER SEQRES 18 A 257 ASN LYS GLY MET GLU HIS LEU TYR SER MET LYS CME LYS SEQRES 19 A 257 ASN VAL VAL PRO LEU SER ASP LEU LEU LEU GLU MET LEU SEQRES 20 A 257 ASP ALA HIS ARG LEU HIS ALA PRO THR SER SEQRES 1 B 257 ILE LYS ARG SER LYS LYS ASN SER LEU ALA LEU SER LEU SEQRES 2 B 257 THR ALA ASP GLN MET VAL SER ALA LEU LEU ASP ALA GLU SEQRES 3 B 257 PRO PRO ILE LEU TYR SER GLU TYR ASP PRO THR ARG PRO SEQRES 4 B 257 PHE SER GLU ALA SER MET MET GLY LEU LEU THR ASN LEU SEQRES 5 B 257 ALA ASP ARG GLU LEU VAL HIS MET ILE ASN TRP ALA LYS SEQRES 6 B 257 ARG VAL PRO GLY PHE VAL ASP LEU THR LEU HIS ASP GLN SEQRES 7 B 257 VAL HIS LEU LEU GLU CME ALA TRP LEU GLU ILE LEU MET SEQRES 8 B 257 ILE GLY LEU VAL TRP ARG SER MET GLU HIS PRO GLY LYS SEQRES 9 B 257 LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN SEQRES 10 B 257 GLY LYS CME VAL GLU GLY MET VAL GLU ILE PHE ASP MET SEQRES 11 B 257 LEU LEU ALA THR SER SER ARG PHE ARG MET MET ASN LEU SEQRES 12 B 257 GLN GLY GLU GLU PHE VAL CYS LEU LYS SER ILE ILE LEU SEQRES 13 B 257 LEU ASN SER GLY VAL TYR THR PHE LEU SER SER THR LEU SEQRES 14 B 257 LYS SER LEU GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU SEQRES 15 B 257 ASP LYS ILE THR ASP THR LEU ILE HIS LEU MET ALA LYS SEQRES 16 B 257 ALA GLY LEU THR LEU GLN GLN GLN HIS GLN ARG LEU ALA SEQRES 17 B 257 GLN LEU LEU LEU ILE LEU SER HIS ILE ARG HIS MET SER SEQRES 18 B 257 ASN LYS GLY MET GLU HIS LEU TYR SER MET LYS CME LYS SEQRES 19 B 257 ASN VAL VAL PRO LEU SER ASP LEU LEU LEU GLU MET LEU SEQRES 20 B 257 ASP ALA HIS ARG LEU HIS ALA PRO THR SER SEQRES 1 C 13 LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER SER SEQRES 1 D 13 LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER SER MODRES 2G5O CME A 381 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 2G5O CME A 417 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 2G5O CME A 530 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 2G5O CME B 381 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 2G5O CME B 417 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 2G5O CME B 530 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 381 10 HET CME A 417 10 HET CME A 530 10 HET CME B 381 16 HET CME B 417 10 HET CME B 530 10 HET DRQ A 201 24 HET DRQ B 555 24 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM DRQ (9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3, HETNAM 2 DRQ 5(10)-TRIENE-3,17-DIOL FORMUL 1 CME 6(C5 H11 N O3 S2) FORMUL 5 DRQ 2(C22 H30 O2) FORMUL 7 HOH *32(H2 O) HELIX 1 1 LEU A 306 LEU A 310 5 5 HELIX 2 2 THR A 311 GLU A 323 1 13 HELIX 3 3 SER A 338 LYS A 362 1 25 HELIX 4 4 THR A 371 SER A 395 1 25 HELIX 5 5 ASN A 413 VAL A 418 5 6 HELIX 6 6 GLY A 420 ASN A 439 1 20 HELIX 7 7 GLN A 441 SER A 456 1 16 HELIX 8 8 GLY A 457 PHE A 461 5 5 HELIX 9 9 GLU A 471 ALA A 493 1 23 HELIX 10 10 THR A 496 LYS A 531 1 36 HELIX 11 11 SER A 537 ALA A 546 1 10 HELIX 12 12 THR B 311 ALA B 322 1 12 HELIX 13 13 SER B 338 LYS B 362 1 25 HELIX 14 14 GLY B 366 LEU B 370 5 5 HELIX 15 15 THR B 371 SER B 395 1 25 HELIX 16 16 ARG B 412 LYS B 416 1 5 HELIX 17 17 GLY B 420 MET B 438 1 19 HELIX 18 18 GLN B 441 SER B 456 1 16 HELIX 19 19 GLY B 457 PHE B 461 5 5 HELIX 20 20 LYS B 472 ALA B 493 1 22 HELIX 21 21 THR B 496 LYS B 531 1 36 HELIX 22 22 SER B 537 HIS B 547 1 11 HELIX 23 23 LYS C 688 ASP C 696 1 9 HELIX 24 24 LYS D 688 LEU D 694 1 7 SHEET 1 A 2 LYS A 401 ALA A 405 0 SHEET 2 A 2 LEU A 408 ASP A 411 -1 O LEU A 408 N ALA A 405 SHEET 1 B 2 LYS B 401 ALA B 405 0 SHEET 2 B 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 LINK C GLU A 380 N CME A 381 1555 1555 1.33 LINK C CME A 381 N ALA A 382 1555 1555 1.33 LINK C LYS A 416 N CME A 417 1555 1555 1.33 LINK C CME A 417 N VAL A 418 1555 1555 1.33 LINK C LYS A 529 N CME A 530 1555 1555 1.33 LINK C CME A 530 N LYS A 531 1555 1555 1.33 LINK C GLU B 380 N CME B 381 1555 1555 1.33 LINK C CME B 381 N ALA B 382 1555 1555 1.33 LINK C LYS B 416 N CME B 417 1555 1555 1.33 LINK C CME B 417 N VAL B 418 1555 1555 1.33 LINK C LYS B 529 N CME B 530 1555 1555 1.33 LINK C CME B 530 N LYS B 531 1555 1555 1.33 SITE 1 AC1 12 HOH A 8 MET A 343 LEU A 346 LEU A 349 SITE 2 AC1 12 ALA A 350 GLU A 353 LEU A 387 ARG A 394 SITE 3 AC1 12 PHE A 404 MET A 421 HIS A 524 LEU A 525 SITE 1 AC2 14 HOH B 25 MET B 343 LEU B 346 LEU B 349 SITE 2 AC2 14 ALA B 350 GLU B 353 LEU B 387 LEU B 391 SITE 3 AC2 14 ARG B 394 PHE B 404 MET B 421 GLY B 521 SITE 4 AC2 14 HIS B 524 LEU B 525 CRYST1 56.069 83.347 58.829 90.00 109.05 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017835 0.000000 0.006158 0.00000 SCALE2 0.000000 0.011998 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017983 0.00000